indican has been researched along with Diabetic Glomerulosclerosis in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 5 (38.46) | 2.80 |
| Authors | Studies |
|---|---|
| Douguchi, S; Hosoya, M; Katoh, M; Ofuchi, K; Osonoi, T; Saito, M | 1 |
| Aliasgharzadeh, A; Jouyban, A; Moradi, M; Oladi-Ghadikolaei, R; Shayanfar, A; Soleymani, J; Tayebi Khosroshahi, H | 1 |
| Balint, L; Bob, F; Cretu, OM; Gadalean, F; Glavan, M; Ienciu, S; Jianu, DC; Milas, O; Mogos, M; Petrica, L; Socaciu, AI; Socaciu, C; Suteanu-Simulescu, A; Vlad, A | 1 |
| Gao, LW; Hu, G; Jian, WX; Tian, Z; Tong, KK; Yang, XY; Yin, S; Yu, YF | 1 |
| Dong, X; Li, P; Ma, L; Peng, L; Wang, Q; Yan, M; Yin, X; Zhang, H; Zhao, H; Zhao, T | 1 |
| Avance, J; Denson, D; Harris, R; Stec, DF; Stothers, C; Voziyan, P; Wang, S | 1 |
| Chen, HH; Chuang, CK; Lin, CJ; Lin, J; Liu, HL; Pan, CF; Sun, FJ; Wang, TJ; Wu, CJ | 1 |
| Barrios, C; Beaumont, M; Bell, JT; Clark, A; Goodrich, JK; Ley, RE; Menni, C; Pallister, T; Pascual, J; Spector, TD; Villar, J | 1 |
| Atoh, K; Haneda, M; Itoh, H | 1 |
| Chiu, CA; Chung, FM; Hsu, CC; Hung, WC; Lee, YJ; Lu, LF; Lu, YC; Tsai, IT; Wang, CP; Yang, CY; Yu, TH | 1 |
| Aoyama, I; Niwa, T; Shimokata, K | 1 |
| Chang, HY; Chuang, FR; Ho, DR; Lin, CL; Wang, IK | 1 |
| Aoyama, I; Niwa, T | 1 |
13 other study(ies) available for indican and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Efficacy and safety of switching from febuxostat to dotinurad, a novel selective urate reabsorption inhibitor, in hyperuricemic patients with type 2 diabetic kidney disease: Protocol for a single-arm, open-label, prospective, exploratory study.
Topics: Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Substitution; Febuxostat; Humans; Hyperuricemia; Indican; Prospective Studies; Uric Acid; Uricosuric Agents | 2022 |
Serum Levels of Indoxyl Sulfate and P-cresol in Type II Diabetic Patients With and Without Nephropathy.
Topics: Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Indican; Proteinuria; Uric Acid | 2023 |
Quantitative, Targeted Analysis of Gut Microbiota Derived Metabolites Provides Novel Biomarkers of Early Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients.
Topics: Arginine; Biomarkers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Gastrointestinal Microbiome; Humans; Indican; Metabolomics; Sulfates | 2023 |
Bibliometric analysis of intestinal microbiota in diabetic nephropathy.
Topics: Bibliometrics; Diabetes Mellitus; Diabetic Nephropathies; Drugs, Chinese Herbal; Gastrointestinal Microbiome; Humans; Indican; Inflammation; Obesity | 2023 |
Tangshen formula modulates gut Microbiota and reduces gut-derived toxins in diabetic nephropathy rats.
Topics: Animals; Bacteria; Cytokines; Diabetic Nephropathies; Disease Models, Animal; Drugs, Chinese Herbal; Dysbiosis; Gastrointestinal Microbiome; Indican; Inflammation Mediators; Intestines; Kidney; Lipopolysaccharides; Male; Rats, Wistar | 2020 |
Alterations of urinary metabolite profile in model diabetic nephropathy.
Topics: Aconitic Acid; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glycine; Hippurates; Indican; Keto Acids; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide Synthase Type III; Phenylacetates | 2015 |
Indoxyl sulfate, not P-cresyl sulfate, is associated with advanced glycation end products in patients on long-term hemodialysis.
Topics: Aged; Biomarkers; Creatinine; Cresols; Cross-Sectional Studies; Diabetic Nephropathies; Female; Glycation End Products, Advanced; Humans; Indican; Male; Middle Aged; Regression Analysis; Renal Dialysis; Renal Insufficiency, Chronic; Sulfuric Acid Esters; Treatment Outcome | 2015 |
Gut-Microbiota-Metabolite Axis in Early Renal Function Decline.
Topics: Adult; Aged; Aged, 80 and over; Body Mass Index; Clostridiales; Cresols; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diseases in Twins; Feces; Female; Fermentation; Gastrointestinal Microbiome; Glomerular Filtration Rate; Glutamine; Humans; Indican; Kidney Diseases; Male; Metabolome; Microbiota; Middle Aged; Ribotyping; Sulfuric Acid Esters | 2015 |
Serum indoxyl sulfate levels in patients with diabetic nephropathy: relation to renal function.
Topics: Adult; Age of Onset; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diagnostic Techniques, Endocrine; Disease Progression; Female; Glomerular Filtration Rate; Humans; Indican; Kidney; Kidney Failure, Chronic; Male; Middle Aged | 2009 |
Increased levels of total P-Cresylsulphate and indoxyl sulphate are associated with coronary artery disease in patients with diabetic nephropathy.
Topics: Case-Control Studies; Coronary Artery Disease; Cresols; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Humans; Indican; Male; Middle Aged; Sulfuric Acid Esters | 2010 |
An oral adsorbent downregulates renal expression of genes that promote interstitial inflammation and fibrosis in diabetic rats.
Topics: Administration, Oral; Adsorption; Animals; Blotting, Northern; Carbon; Chemokine CCL2; Clusterin; Diabetic Nephropathies; Fibrosis; Gene Expression; Glycoproteins; Immunohistochemistry; Indican; Intercellular Adhesion Molecule-1; Kidney; Male; Molecular Chaperones; Osteopontin; Oxides; Rats; Rats, Inbred OLETF; Rats, Long-Evans; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sialoglycoproteins; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2002 |
Purple urine bag syndrome in a hemodialysis patient.
Topics: Bacteria; Color; Diabetic Nephropathies; Female; Fermentation; Humans; Indican; Indigo Carmine; Indoles; Middle Aged; Plastics; Renal Dialysis; Urinary Catheterization | 2005 |
An oral adsorbent ameliorates renal overload of indoxyl sulfate and progression of renal failure in diabetic rats.
Topics: Administration, Oral; Animals; Blood Urea Nitrogen; Carbon; Cholesterol; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Immunohistochemistry; Indican; Kidney; Kidney Failure, Chronic; Kidney Glomerulus; Male; Oxides; Rats; Rats, Inbred OLETF; Rats, Long-Evans; Treatment Outcome; Triglycerides | 2001 |